Drugs / Fluticasone/Salmeterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00252863 | Dec 2004 → May 2006 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone/Salmeterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00252863 ↗ |
| Route | Inhaled | “Fluticasone/Salmeterol Discus 250/50 µg” NCT00252863 ↗ |